Company Overview
Snapshot
Founded in February 2003 by Ben Beiski and Andy Wolff, Saliwell operates with 1–10 employees. The company has raised $2.18 million across one funding round. In November 2018, Saliwell's device for stimulating saliva production was trialled at Great Western Hospital, highlighting its clinical validation.
Business overview
Saliwell develops medical devices for the treatment of dry mouth disease, also known as xerostomia. Its core product, the SaliPen, utilizes electro-stimulation to naturally increase saliva production. The device features two flexible arms with stimulating electrodes designed for intraoral placement underneath the tongue, offering a practical and effective solution for patients. Saliwell operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving patients globally.
Strategic signal
In November 2018, Saliwell's SaliPen device was trialled at Great Western Hospital, a significant step in validating its efficacy for patients suffering from dry mouth. This clinical trial signals the company's commitment to rigorous testing and demonstrates potential for broader adoption in healthcare settings, indicating a positive trajectory for market entry and patient impact.
Log in to access full profile ›Company Intelligence Q&A
- What is Saliwell's primary product?
- Saliwell's primary product is the SaliPen, a device designed to stimulate natural saliva production to treat dry mouth disease (xerostomia) using electro-stimulation.
- When was Saliwell founded and by whom?
- Saliwell was founded in February 2003 by co-founders Ben Beiski and Andy Wolff.
- What was a key development for Saliwell in late 2018?
- In November 2018, Saliwell's device for stimulating saliva production was trialled at Great Western Hospital, marking a significant step in its clinical development.
- What was a notable corporate event for Saliwell in 2011?
- In January 2011, Atia Group shareholders approved a merger with Saliwell, a transaction that integrated the two companies.
- How much capital has Saliwell raised?
- Saliwell has raised a total of $2.18 million across one disclosed funding round.